Network‐Based Drug Repurposing and Genomic Analysis to Unveil Potential Therapeutics for Monkeypox Virus
Chemistry & Biodiversity · 2024
DOI: 10.1002/cbdv.202400895 ↗Kurz gefasst
Fachartikel in der Zeitschrift Chemistry & Biodiversity, 2024. Verfasst von Ali A Rabaan und 7 weiteren Autor:innen. Beteiligte Einrichtung: Molecular Diagnostic Laboratory, Johns Hopkins Aramco Healthcare, Dhahran, 31311, Saudi Arabia. Hauptthemen laut MEDLINE: Drug Repositioning, Antiviral Agents, Monkeypox virus. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 114 Literaturangaben. Gefördert von: Prince Sattam bin Abdulaziz University.
Abstract (Originalsprache)
The emergence of the human monkeypox virus (MPXV) and the lack of effective medications have necessitated the exploration of various strategies to combat its infection. This study employs a network‐based approach to drug discovery, utilizing the BLASTn and phylogenetic analysis to compare the MPXV genome with those of 18 related orthopoxviruses, revealing over 75 % genomic similarity. Through a literature review, 160 human‐host proteins linked to MPXV and its relatives were identified, leading to the construction of a human‐host protein interactome. Analysis of this interactome highlighted 39 central hub proteins, which were then examined for potential drug targets. The process successfully revealed 15 targets already approved for use with medications. Additionally, the functional enrichment analysis provided insights into potential pathways and disorders connected with these targets. Four medications, namely Baricitinib, Infliximab, Adalimumab, and Etanercept, have been identified as potential candidates for repurposing to combat MPXV. In addition, the pharmacophore‐based screening identified a molecule that is comparable to Baricitinib and has the potential to be effective against MPXV. The findings of the study suggest that ZINC22060520 is a promising medication for treating MPXV infection and proposes these medications as potential options for additional experimental and clinical assessment in the battle against MPXV.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Molecular Diagnostic Laboratory, Johns Hopkins Aramco Healthcare, Dhahran, 31311, Saudi Arabia.
- College of Medicine, Alfaisal University, Riyadh, 11533, Saudi Arabia.
- Department of Public Health and Nutrition, The University of Haripur, Haripur, 22610, Pakistan.
- Department of Microbiology, National Reference laboratory, Cleveland Clinic Abu Dhabi, Abu Dhabi, 92323, United Arab Emirates.
- Department of Pathology, College of Medicine, Mohammed Bin Rashid, University of Medicine and Health Sciences, Dubai, 505055, United Arab Emirates.
- Department of Pharmacy Practice, College of Pharmacy, Princess Nourah bint Abdulrahman University, Riyadh, 11671, Saudi Arabia.
ORCID-Profile: Ali A Rabaan
Förderung
- Prince Sattam bin Abdulaziz University
Zitieren
APA
Rabaan, A. A., Alfaresi, M., Alrasheed, H. A., Al Kaabi, N. A., Abduljabbar, W. A., Al Fares, M. A., Al-Subaie, M. F., & Alissa, M. (2024). Network‐Based Drug Repurposing and Genomic Analysis to Unveil Potential Therapeutics for Monkeypox Virus. Chemistry & Biodiversity. https://doi.org/10.1002/cbdv.202400895
Vancouver
Rabaan AA, Alfaresi M, Alrasheed HA, Al Kaabi NA, Abduljabbar WA, Al Fares MA, et al. Network‐Based Drug Repurposing and Genomic Analysis to Unveil Potential Therapeutics for Monkeypox Virus. Chemistry & Biodiversity. 2024. doi:10.1002/cbdv.202400895
BibTeX
@article{Rabaan2024,
author = {Rabaan, Ali A and Alfaresi, Mubarak and Alrasheed, Hayam A and Al Kaabi, Nawal A and Abduljabbar, Wesam A and Al Fares, Mona A and Al-Subaie, Maha F and Alissa, Mohammed},
title = {Network‐Based Drug Repurposing and Genomic Analysis to Unveil Potential Therapeutics for Monkeypox Virus},
journal = {Chemistry & Biodiversity},
year = {2024},
doi = {10.1002/cbdv.202400895}
}
EUVIMED